Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Liked these lines from the Stockhead piece.
“Our focus is not on profit… our focus is on growing revenues and taking advantage of the growing space to increase our market share. We feel that that is the most important thing to do right now,” he told Stockhead.
This year, nearly 20 per cent of revenue will be spent on marketing.
When legislation lifts the lid off of hemp cbd, things will progress quickly. Hopefully we can double revenue this yoy.
ELLXF: The Pot Seat: Elixinol’s Paul Benhaim is spending to stay on top
https://stockhead.com.au/food-agriculture/the-pot-seat-elixinols-paul-benhaim-is-spending-to-stay-on-top/
Easyjet's Inflight full page ELLXF Ad
Great to see the @Elixinol brand making its presence felt in Europe, with this full-page advertisement for our #CDB Oil in Easyjet’s inflight magazine! pic.twitter.com/fZMWdiqzYB
— Elixinol Wellness Limited (@EXLWellness) March 5, 2019
No I didn’t argue. You guys argued with me. I simply said “naah” and then afterwards all the bad information came out of both your mouths.
And my point is, if a guy wants to go recommend this stock to his family, friends or "social media" than as an investor you should be way okay with that. But instead you decide to argue with him about it lol facepalm
Have some context. This conversation started out with “Help spread the word of this 'hidden' hemp gem investment”
I replied, no, it’s not necessary.
And now you’re telling me volume is exposure and awareness.
The stock is about to fly and you can barely see it. You guys are just impatient. I say within two weeks it’ll be over $3. Please go blow up your email lists and social media to help it run. /facepalm
And what do you think it is that will make it take off...? VOLUME. Which IS investor awareness
When I see something that’s simply not true I sometimes do make it a point to correct people. This stock is about to take off: what investor awareness is needed to get it to run? That’s just silly, man.
You're climbing an uphill battle here trying to deny the importance of volume and investor awareness. It's a very simple and logical point this gentleman brought up. I think you just like to argue. I've seen you do it on the other board as well
My point is that is a nonevent. This chart is clear as day about to RUN, so SOMEONE must be buying it and speculating it’s about to go higher. Here’s some truth: the MOST volume comes in at the highs and tops
I agree. IMO this company is so undervalued because of the lack of awareness. That's why volume is so important deadjim. I'm sure we all know you need volume to increase (sustainable) share price
Gras status from the fda would help....
We're talking exposure/ increased investor awareness not necessarily popularity.
Eh, popularity doesn’t mean price move. It’ll go it’s own pace
Yes, imo.
I'm a big fan of Elixinol, but the low daily volume itself, among other factors, shows that the company needs much more media exposure.
The last time I checked, there were no professional institutional investors/funds, etc. That needs to change.
Again, I'm a big fan of the company, but it remains a secret in the larger investing world. Plans to uplist to NYSE or NASDAQ would be hge.
ELLXF: Elixinol Global Makes Hemp Play in $215 Million Vegan Food Sector
https://thegreenfund.com/elixinol-global-makes-hemp-play-in-215-million-vegan-food-sector
It badly needs media/analyst exposure.
Being an Australian stock, as good as it is, more media exosure, especially in the US is needed.
With that will come knowledge of his hemp gem and dramatically increased volume which will be very bullish for the stock.
Help spread the word of this 'hidden' hemp gem investment.
Oh. Well if it starts to lift from this area it’s gone
I'm referring to the trend (support) line on the daily that it has hit 4 times now, currently running through the 2.30 area. I've got ammunition on the side just in case it does test that before take off
HEMP is so versatile, there are massive products and revenues to be made, as ELIXINOL has shown us and as the US did some 80 plus years ago before being mistakenly declared illegal in the US.
That's all dramatically changed now in the US and soon for ELIXINOL getting it's medical production license.
I don’t know which trend line you’re looking at but it can really do anything. I think this is a pennant so if it’s real you won’t get probably anything under 2.40s
Do you think there is a chance it could retest the trend line before take off?
thanks....a HUGE PLUS.....debt free.
check out ELLXF"S chart....a thing of beauty!
Under constant 'quiet accumulation'
needs more analsts/media attention and that surely is happening now with the exploding investment world of HEMP!
a steal at 2.50 a share.
will buy more on monday.
Don't forget, no real debt.
Absolutely correct.
ELLXF has everything going for it:
-very low float
-revenues doubling over last year
-profitable
-doing business internationally
-huge expansion in US underway
-plans to uplist to NYSE or NASDAQ in the works
-in the hottest investment sector, HEMP products
-a ridiculously low share price of 2.50
-a 'hidden gem', awaiting analyst increased exposure.
-a Buy for truly smart investors.
Sorry, don't know.
It is in the works and my guess should be in days?
Chasing a pennant! AL or NL? Doesn't matter. They are about to raise the flag pole. Oh boy
All you can eat here 2.50s
Flagging at 2.50. Huge liftoff about to occur and everybody will know about it ..lol @/&&;$;&
Yw. I just got a new shipment too.
Whenever Australia decides to issue it. Unknown.
When do they get their medical marijuana license???
PLEASE HELP BY DOING ALL YOU CAN TO SPREAD THE WORD OF ELLXF.
BEING AN AUSTRALIAN BASED STOCK, IT IS NOT WELL KNOWN. GLTY.
This is flying under the radar. One big announcement connecting this company to another well known name and this one flies. I've been watching the accumulation at this level for weeks. When it moves up it will be swift and meaningful
ELLXF - a CBD PROFITABLE INTERNATIONAL REVENUE GENERATING GEM!
FY2018 revenue up 121% to 37.1 million.
Very strong balance sheet, with net cash of 42.7 million to drive international hemp growth
In the hemp business for over 30 years and implementing a major international presence, especially in the US.
An Australian basedd hidden 'gem'.
Help spread the awareness of ELLXF
ELLXF is a 'hidden gem' in the vast CBD world.
Coming earnings and company expansion internationally.especially in the US, will attract a whole new group of investors now aware of the company's scope and exploding revenues and earnings. in the CBD world.
The stoc k's been under steady accumulation with a low float and I expe t ome big moves following coming financial reports.
Thanks for the help, lhal. Easy and quick to order.
An experienced, successful and profitable CBD company, in the CBD business for years and great plans to expand in US and western hemisphere.
A sure winner, under growing accumulation and investor awareness.
A sure portfolio stock in one of the hottest growing market sector.
News still hasn't shown up on ELLXF website or in my email. Pretty exciting new product!
Cannabis Companies Beginning To Ante Up For Bets On Hemp
[Benzinga]
New Frontier Data
BenzingaFebruary 27, 2019
Last week, the hemp and cannabis markets were abuzz with news that cannabis giant Tilray Inc. (NASDAQ: TLRY) was acquiring Manitoba Harvest for $419 million CAD ($319 million USD). Manitoba is the world’s largest hemp-foods manufacturer, with products in more than 16,000 retail stores throughout North America.
For Tilray specifically, the move represents a significant step in its attempt to stake a claim in the U.S. hemp market. In a broad sense, the acquisition reflects the growing trend of cannabis operators’ seeking to acquire hemp companies in aims to stake claims in the ever-expanding hemp-CBD market, and sets the stage for an increasingly competitive and dynamic year for the hemp industry.
The Hemp Business Journal estimates that sales generated by the hemp-CBD market will grow from $390 million in 2018, to one worth approximately $1.3 billion by 2022. As U.S. cannabis companies continue to struggle under federal prohibition, and as Canadian operators continue to look for ways to grow their brands, the hemp-CBD market presents attractive possibilities.
Because of the 2018 Farm Bill, hemp and its derivatives are now treated as agricultural products rather than controlled substances. Per agricultural products, there are far fewer financial and regulatory barriers for companies looking to corner the hemp market, while there exist any number of opportunities for cannabis companies seeking to generate additional revenue from segments such as hemp foods.
Hemp-CBD may be considered a hot commodity in today’s market, but regulators throughout the United States and Europe have been slow to embrace its use. In the United States, states are cracking down on businesses that sell edibles products containing CBD, and the U.S. Food and Drug Administration (FDA) continues to send warning letters to companies marketing CBD supplements as health products.
Similarly in Europe, the hemp-CBD market is experiencing its own obstacles. Recently, the European Food Safety Authority classified CBD as a “novel food” additive, which means that companies producing CBD-based food products or extracts will have to put their products through a safety evaluation before earning placement in the European market.
Hemp food products that do not contain CBD, meantime, have not been subject to the same limitations. That makes Tilray’s acquisition that much more significant: While regulators in both the U.S. and EU take their time determining how to regulate CBD, Tilray will be generating revenue through Manitoba’s existing products. Once the CBD issue is resolved, Tilray will thus be better positioned to pivot towards hemp-CBD.
Other cannabis companies have adopted similar models to Tilray’s. One company which has found success straddling the fence between hemp and cannabis is Elixinol Global (OTC: ELLXF).
Elixinol Global is the parent company of three businesses: Hemp Foods Australia, Elixinol (which sells CBD products), and Nunyara (a medical cannabis company seeking licensure in Australia). Over the last year, Elixinol Global has seen its sales grow by 121%, to approximately $26 million. The vast majority of that growth has been driven by sales of CBD products.
Two of the other biggest cannabis companies (besides Tilray) looking to capitalize on the growth of the hemp-CBD market are Aurora Cannabis (NYSE: ACB) and Canopy Growth Corp. (NYSE: CGC).
Late last year, Aurora announced that they would acquire Europe’s largest organic hemp company, Agropro UAB, and its sister company Borela UAB (which processes and distributes hemp) for $9.5 million CAD. Though little has been heard about Aurora’s hemp plans, there are rumors that the company is in “serious talks” with Coca-Cola to develop a line of CBD beverages. If those rumors turn out to be true, Aurora could instantly become a powerful force in the hemp industry.
Instead of acquiring an existing hemp company like Aurora and Tilray, Canopy Growth seems to be laying the groundwork for setting up its hemp infrastructure. Late last month, Canopy announced that it had received licensing to cultivate and process hemp in the state of New York. So far, Canopy has pledged to invest $500 million in its hemp production capacity, and hopes to expand its hemp footprint to two more states.
While regulators continue to grapple with the question of how to regulate CBD, the cannabis industry is betting big on hemp-CBD. Though no clear leader in this sector has yet emerged, one thing is certain: The hemp and cannabis segments are becoming increasingly intertwined.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
https://finance.yahoo.com/news/cannabis-companies-beginning-ante-bets-222746649.html
ELLXF: Elixinol Launches Water-Soluble Flavored CBD Powder with Proprietary Full-Spectrum Blends
By GlobeNewswire, February 28, 2019, 02:45:00 PM EDT
Leading Hemp-Derived CBD Brand Enters New Category as Demand for CBD Beverages Increases
DENVER, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces its latest product innovation, Create | Build | Dream (C | B | D), a full-spectrum water-soluble hemp CBD powder. The C | B | D powder comes in three distinct flavors and proprietary terpene profiles - berry, citrus and cocoa - each optimized for varying energy needs throughout the day, from a morning boost to an afternoon pick-me-up or evening relaxation.
Each water-soluble flavor is gluten-free, non-GMO, dairy-free and vegan, and is packaged in easy-to-use single-serving sachets, making daily consumption especially convenient for on-the-go consumers. Powered by OLEO™, Elixinol C | B | D powder offers double the bioaccessibility of regular CBD, meaning higher potency and greater potential accessibility. The packets are easy to mix into the hot or cold beverages wellness-driven consumers are already drinking throughout their day like smoothies, water or tea.
CREATE, with its uplifting berry flavor, is perfect for adding to a morning smoothie, helping to increase alertness with 10mg of full-spectrum hemp CBD.
BUILD, the bright midday citrus flavor, is perfect for adding to tea or water and is formulated to help manage energy slumps and increase focus, as well as temporarily reduce exercise-induced pain, with 10mg of full-spectrum hemp CBD.
DREAM, specially designed for hot beverages, contains a 5mg serving of cocoa-flavored full-spectrum hemp CBD to aid relaxation in preparation for a good night's sleep.
"Our CBD powders are all-natural, taste great and mix well with beverages, no matter the time of day," said Chris Husong, Elixinol's Sales & Marketing Director. "Imagine you're feeling tired after a long day, but you have to rally for a business dinner. Instead of having another cup of coffee, mix BUILD into your afternoon water to push you through the evening in a focused and productive way - without the jitters or potentially unwanted effects of caffeine. Or, if you're having trouble falling and staying asleep after a particularly intense day, DREAM will help you get the much-needed rest for your busy day tomorrow."
CBD, or cannabidiol, is one of many naturally occurring compounds called cannabinoids, which are found in humans, animals and plants. Consuming CBD replenishes the natural cannabinoids that are generated by our body's endocannabinoid system. A full-spectrum CBD extract contains all of the cannabinoids, terpenes, antioxidants, phytonutrients and flavonoids that are naturally present in the hemp plant, whereas an isolated CBD strips away most of these beneficial ingredients to produce a more manufactured product.
"The proprietary formulation of Elixinol's Colorado-grown and extracted full-spectrum CBD allows for precise serving sizes, and an even more efficient and effective absorption process, thanks to our partnership with OLEO," said Gabriel Ettenson, President of Elixinol. "We're proud to help consumers navigate the rapidly growing CBD marketplace by offering quality products and quality delivery systems."
"We are thrilled to be partnering with Elixinol to help them create this line of groundbreaking Powered by OLEO™ products using our microencapsulation process. Our technology complements Elixinol's premium full-spectrum hemp extracts by providing increased bioaccessibility and removal of any bitter aftertaste," said Skyler Bissell, CEO of OLEO.
Elixinol C | B | D powder is available at Elixinol.com/product/category/cbd-powder for a suggested retail price of $59.99 for one 30-pack or $44.99 for one 21-count sampler pack.
About Elixinol
Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands with complete seed-to-sale control over its products. Elixinol also conducts rigorous third-party laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries globally including North and South America, throughout Europe, Asia, and the Pacific Region under its own label as well as bulk CBD and wholesale CBD. Elixinol is a wholly owned subsidiary of Elixinol Global (EXL) (elixinolglobal.com) which is publicly traded on the Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX:ELLXF). More information available at Elixinol.com.
About OLEO
Founded in 2015, OLEO is a food technology company who specializes in powder formulations using a patent-pending cannabinoid micro-encapsulation that dissolves quickly in cold water. The OLEO micro-encapsulation process has been shown to double the bioaccessibility (potency) of CBD versus typical CBD oil over the first two hours after consumption.
Media Contacts:
Blythe Tokar
+1 202-292-4573
elixinol@wearemultip.ly
Chris Husong
Elixinol
+1 844-804-3504 ext 420
I was thinking about eating one earlier.
Who's up for a Hemp burger?
https://twitter.com/ElixinolGlobal
I love this presentation. They have $43mln in cash !
Followers
|
26
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1174
|
Created
|
09/18/18
|
Type
|
Free
|
Moderators |
50 Pitt Street,
Level 6
Sydney, NSW 2000
Australia
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |